| Breakdown | Mar 2026 | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 2.76T | 2.51T | 2.41T | 2.48T | 2.10T |
| Gross Profit | 367.49B | 317.76B | 299.98B | 314.84B | 252.35B |
| EBITDA | 62.37B | 121.02B | 126.53B | 154.70B | 125.28B |
| Net Income | 103.61B | 110.64B | 100.77B | 111.25B | 82.33B |
Balance Sheet | |||||
| Total Assets | 3.65T | 3.17T | 2.97T | 2.72T | 2.71T |
| Cash, Cash Equivalents and Short-Term Investments | 256.05B | 199.18B | 209.41B | 254.28B | 282.43B |
| Total Debt | 1.40T | 1.19T | 1.01T | 955.11B | 1.13T |
| Total Liabilities | 2.49T | 2.16T | 2.02T | 1.84T | 1.95T |
| Stockholders Equity | 1.09T | 968.96B | 924.08B | 837.71B | 728.01B |
Cash Flow | |||||
| Free Cash Flow | -23.30B | -60.05B | 85.09B | 145.96B | 46.71B |
| Operating Cash Flow | 16.76B | -16.69B | 112.19B | 171.64B | 65.08B |
| Investing Cash Flow | -89.63B | -90.81B | -8.60B | 30.72B | -140.28B |
| Financing Cash Flow | 113.24B | 103.09B | -165.49B | -231.93B | 48.35B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | ¥8.57T | 9.00 | 12.86% | 2.48% | 0.62% | 7.66% | |
69 Neutral | ¥9.08T | 20.63 | 13.39% | 2.29% | 6.11% | 9.13% | |
69 Neutral | ¥18.22T | 25.47 | 7.39% | 2.94% | 1.60% | -10.27% | |
68 Neutral | ¥15.63T | 17.70 | 15.23% | 2.11% | 0.67% | 3.97% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
60 Neutral | ¥1.08T | 13.95 | 11.17% | 3.24% | 9.87% | -3.76% | |
54 Neutral | ¥15.64T | 19.09 | 11.47% | 2.28% | -4.55% | -5.17% |